Explore more Categories
Artificial Intelligence involves the science and engineering of developing intelligent machines
The manufacturing world is at a cusp of a new revolution that will redefine conventional business models
IoT will have a major impact on businesses and consumers in the future
The world is creating 2.5 exabytes of data daily
Our research seeks to connect-the-dots across multiple trends
Personal Robots are Set to Be a $19 Billion Market
Strategic Analysis of BREXIT and its Implications to Industries, Economies and Societies
iFrost is a digital platform for interactive and dynamic reporting of data.
The TOEs are a great source of information which gives corporates critical information on companies to action for their strategic investments either as an open source platform or to collaborate and to develop successful products
Global Diabetes Epidemic Adds Urgency to R&D Initiatives, Inhalable and Transdermal Delivery on Upward Trajectory
save 25 %
* Required Fields
Pay by invoice
Diabetes has exhibited dramatic increases during the past decade, registering a global prevalence of 9% among adults aged 18 years and older, and is projected to be the 7th-leading cause of death by 2030. The most popular treatment for type 1 diabetes mellitus (T1DM) is multiple daily insulin (MDI) injections. However, researchers globally are working on both the development of novel drugs to fight diabetes, and on the design of novel insulin delivery systems. These delivery systems mostly via use oral and pulmonary routes using nanocarrier-based delivery systems, as well as transdermal delivery to through patches and infusion pumps, which aim to improve the quality of life of diabetic patients. An important new business model is emerging between large pharmaceutical/biopharmaceutical companies and medical devices firms with the objective of accelerating the delivery of novel therapeutic systems to the industry. Medical device companies and drug manufacturing companies sign long-term partnership agreements to combine their drug delivery devices with the most-active diabetes therapeutics, thereby bringing down the operational costs and saving a significant amount of time during the process.This research service (RS) examines the current landscape and new trends in diabetes drug delivery, focusing on:Technology trends and capabilityStakeholder activities, influence, industry initiatives, and applications targetedIndustry initiatives, regulation, and standardization approaches for tackling challengesTechnology benchmarking for specific applications An appendix is included, comprising lists of the major participants in the study and the most notable patents in the field.
Health & Wellness Top 10 Technologies--2016 (TechVision)
2016 Top Technologies in Medical Devices and Imaging (TechVision)
Diagnostic Breakthroughs for Neurodegenerative Diseases
Innovations in Global Proteomics Technologies Market
Collaboration between Medical Devices, Pharmaceuticals, and Biotechnology
Advanced mechanisms in drug delivery
Advances in monoclonal antibody therapeutics
Advanced Techniques and Applications in Optical Imaging (TechVision)
Trends in mammalian cell cultures
Top Health and Wellness Technologies in 2015 (Technical Insights)
smart lighting market
residential solar market
packaged food industry
mobile biometrics market
wound care market
food preservatives market
fuel cell market
blood glucose monitoring market
flexible electronics market
solar panel market
Fill in the fields below to receive a sample report
Don't have an account? Create One!
Enter your Email Address here to receive a link to change password.
If you are an existing frost.com user, please register using the same email for seamless access
Already have an account? Login!
Use your Linkedin account to login or register within our store.You're just one click away.